ArticleInternational journal of biological sciences2026
Spinal glycine receptor alpha 1 coordinates startle behavior through a cell-type specific mechanism.
Article in International journal of biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The spinal cord critically regulates startle responses through local excitatory and inhibitory circuits. The glycine receptor alpha 1 subunit (GlyRα1) mediates the primary inhibitory neurotransmission in the spinal cord, however, the contribution of spinal glycinergic inhibition to startle regulation remains poorly understood. Here, we show that GlyRα1 controls startle behavior in a cell-type- and region-specific manner. GlyRα1 deletion in ChAT-positive spinal neurons markedly enhances startle responses and c-Fos activation in spinal motor neurons as well as excitatory interneurons. In contrast, GlyRα1 deletion in inhibitory interneurons suppresses startle behavior while selectively increasing spinal c-Fos activation in inhibitory but not excitatory interneurons. Consistent with these findings, intraspinal AAV-Cre induced deletion of GlyRα1 without cell-type specificity increases startle responses, whereas deletion from spinal CamK2α-positive cells, which predominantly overlap with glycinergic inhibitory interneurons, attenuates startle reflexes. By contrast, deletion of GlyRα1 from brainstem RtTg CamK2α-positive cells, which are predominantly glutamatergic, enhances startle responses. GlyRα1 deficiency in glycinergic neurons reduces the amplitude of puff-applied glycine-elicited currents without affecting synaptic inhibitory and excitatory neurotransmission in the spinal cord. Together, these findings identify spinal GlyRα1 subunits as a cell-type specific regulator of startle behavior and reveal opposing contributions of GlyRα1 signaling in spinal inhibitory interneurons and motor/excitatory output pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.